亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

上海畢得醫藥科技有限公司  

主要生產環化合藥物包括吲哚,咪唑,吡唑,噠嗪,吡啶,嘧啶,哌嗪,哌啶,哌咯,噻唑,三唑類和其它醫藥中間體。

搜索
新聞中心
產品分類
  • 暫無分類
聯系方式
  • 聯系人:馬
  • 電話:86-21-61629020
  • 郵件:marketing_cn@bidepharmatech.com
  • 傳真:86-21-61629029
  • QQ:2959064341
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 六氟磷酸苯并三唑-1-基-氧基三吡咯烷
六氟磷酸苯并三唑-1-基-氧基三吡咯烷
單價 面議對比
詢價 暫無
發貨 上海付款后3天內
品牌 上海畢得醫藥科技有限公司
過期 2017-10-18 已過期
更新 2016-10-24 08:42
該化工產品已過期
詳細信息
 Product name:((1H-Benzo[d][1,2,3]triazol-1-yl)oxy)tri(pyrrolidin-1-yl)phosphonium hexafluorophosphate(V)
Chinese Name (中文名稱):六氟磷酸苯并三唑-1-基-氧基三吡咯烷
BD Catalog No.:BD16967
CAS No.:128625-52-5
庫存:1004.85
MDL Number:MFCD00077411
Molecular Formula(分子式):C18H28F6N6OP2
Molecular Weight(分子量):520.39
smile code:F[P-](F)(F)(F)(F)F.N1([P+](N2CCCC2)(ON3N=NC4=CC=CC=C43)N5CCCC5)CCCC1
Storage:Refrigerated (2-8°C)
Shelf Life(days):365 days
©2025 上海畢得醫藥科技有限公司 版權所有   技術支持:化工網   訪問量:7529  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |